298 related articles for article (PubMed ID: 17530993)
1. Emergence of NNRTI drug resistance mutations after single-dose nevirapine exposure in HIV type 1 subtype C-infected infants in India.
Kurle SN; Gangakhedkar RR; Sen S; Hayatnagarkar SS; Tripathy SP; Paranjape RS
AIDS Res Hum Retroviruses; 2007 May; 23(5):682-5. PubMed ID: 17530993
[TBL] [Abstract][Full Text] [Related]
2. Slower clearance of nevirapine resistant virus in infants failing extended nevirapine prophylaxis for prevention of mother-to-child HIV transmission.
Persaud D; Bedri A; Ziemniak C; Moorthy A; Gudetta B; Abashawl A; Mengistu Y; Omer SB; Isehak A; Kumbi S; Adamu R; Lulseged S; Ashworth R; Hassen E; Ruff A;
AIDS Res Hum Retroviruses; 2011 Aug; 27(8):823-9. PubMed ID: 21241214
[TBL] [Abstract][Full Text] [Related]
3. Characterization of nevirapine (NVP) resistance mutations and HIV type 1 subtype in women from Abidjan (Côte d'Ivoire) after NVP single-dose prophylaxis of HIV type 1 mother-to-child transmission.
Toni TD; Masquelier B; Lazaro E; Dore-Mbami M; Ba-Gomis FO; Téa-Diop Y; Kouakou K; Diby J; Sia E; Soppi S; Essien S; Schrive MH; Pinson P; Chenal H; Fleury HJ
AIDS Res Hum Retroviruses; 2005 Dec; 21(12):1031-4. PubMed ID: 16379606
[TBL] [Abstract][Full Text] [Related]
4. A post-partum single-dose TDF/FTC tail does not prevent the selection of NNRTI resistance in women receiving pre-partum ZDV and intrapartum single-dose nevirapine to prevent mother-to- child HIV-1 transmission.
Samuel R; Paredes R; Parboosing R; Moodley P; Singh L; Naidoo A; Gordon M
J Med Virol; 2015 Oct; 87(10):1662-7. PubMed ID: 25940687
[TBL] [Abstract][Full Text] [Related]
5. Drug resistance in plasma and breast milk after single-dose nevirapine in subtype C HIV type 1: population and clonal sequence analysis.
Kassaye S; Lee E; Kantor R; Johnston E; Winters M; Zijenah L; Mateta P; Katzenstein D
AIDS Res Hum Retroviruses; 2007 Aug; 23(8):1055-61. PubMed ID: 17725424
[TBL] [Abstract][Full Text] [Related]
6. Nevirapine resistance after single dose prophylaxis.
Eshleman SH; Jackson JB
AIDS Rev; 2002; 4(2):59-63. PubMed ID: 12152519
[TBL] [Abstract][Full Text] [Related]
7. Genetic linkage of nevirapine resistance mutations in HIV type 1 seven days after single-dose nevirapine.
Jones D; Parkin N; Hudelson SE; Guay LA; Musoke P; Mmiro F; Jackson JB; Eshleman SH
AIDS Res Hum Retroviruses; 2005 Apr; 21(4):319-24. PubMed ID: 15943576
[TBL] [Abstract][Full Text] [Related]
8. HIV type 1 pol gene diversity and archived nevirapine resistance mutation in pregnant women in Rwanda.
Servais J; Lambert C; Karita E; Vanhove D; Fischer A; Baurith T; Schmit JC; Schneider F; Hemmer R; Arendt V
AIDS Res Hum Retroviruses; 2004 Mar; 20(3):279-83. PubMed ID: 15117451
[TBL] [Abstract][Full Text] [Related]
9. Selection and fading of resistance mutations in women and infants receiving nevirapine to prevent HIV-1 vertical transmission (HIVNET 012).
Eshleman SH; Mracna M; Guay LA; Deseyve M; Cunningham S; Mirochnick M; Musoke P; Fleming T; Glenn Fowler M; Mofenson LM; Mmiro F; Jackson JB
AIDS; 2001 Oct; 15(15):1951-7. PubMed ID: 11600822
[TBL] [Abstract][Full Text] [Related]
10. Resistance mutations in HIV-1 infected pregnant women and their infants receiving antiretrovirals to prevent HIV-1 vertical transmission in China.
Han J; Wang L; Jiang Y; Zhang Q; Fang L; Yao J; Wang Q
Int J STD AIDS; 2009 Apr; 20(4):249-54. PubMed ID: 19304969
[TBL] [Abstract][Full Text] [Related]
11. Comparison of genotypic resistance profiles and virological response between patients starting nevirapine and efavirenz in EuroSIDA.
Bannister WP; Ruiz L; Cozzi-Lepri A; Mocroft A; Kirk O; Staszewski S; Loveday C; Karlsson A; Monforte Ad; Clotet B; Lundgren JD;
AIDS; 2008 Jan; 22(3):367-76. PubMed ID: 18195563
[TBL] [Abstract][Full Text] [Related]
12. Zidovudine with nevirapine for the prevention of HIV mother-to-child transmission reduces nevirapine resistance in mothers from the Western Cape, South Africa.
van Zyl GU; Claassen M; Engelbrecht S; Laten JD; Cotton MF; Theron GB; Preiser W
J Med Virol; 2008 Jun; 80(6):942-6. PubMed ID: 18428139
[TBL] [Abstract][Full Text] [Related]
13. Characterization of HIV type 1 reverse transcriptase mutations in infants infected by mothers who received peripartum nevirapine prophylaxis in Jos, Nigeria.
Ojesina AI; Mullins C; Imade G; Samuels J; Sankalé JL; Pam S; Sagay S; Idoko J; Kanki PJ
AIDS Res Hum Retroviruses; 2007 Dec; 23(12):1587-92. PubMed ID: 18160018
[TBL] [Abstract][Full Text] [Related]
14. Detection of K103N in Ugandan women after repeated exposure to single dose nevirapine.
Flys TS; Mwatha A; Guay LA; Nakabiito C; Donnell D; Musoke P; Mmiro F; Jackson JB; Eshleman SH
AIDS; 2007 Oct; 21(15):2077-82. PubMed ID: 17885298
[TBL] [Abstract][Full Text] [Related]
15. Comparison of nevirapine (NVP) resistance in Ugandan women 7 days vs. 6-8 weeks after single-dose nvp prophylaxis: HIVNET 012.
Eshleman SH; Guay LA; Mwatha A; Cunningham SP; Brown ER; Musoke P; Mmiro F; Jackson JB
AIDS Res Hum Retroviruses; 2004 Jun; 20(6):595-9. PubMed ID: 15242535
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of resistance to nevirapine in mothers and children after single-dose exposure to prevent vertical transmission of HIV-1: a meta-analysis.
Arrivé E; Newell ML; Ekouevi DK; Chaix ML; Thiebaut R; Masquelier B; Leroy V; Perre PV; Rouzioux C; Dabis F;
Int J Epidemiol; 2007 Oct; 36(5):1009-21. PubMed ID: 17533166
[TBL] [Abstract][Full Text] [Related]
17. Polymorphisms and drug resistance analysis of HIV-1 CRF01_AE strains circulating in Fujian Province, China.
Liu J; Yue J; Wu S; Yan Y
Arch Virol; 2007; 152(10):1799-805. PubMed ID: 17619115
[TBL] [Abstract][Full Text] [Related]
18. Minor drug-resistant HIV type-1 variants in breast milk and plasma of HIV type-1-infected Ugandan women after nevirapine single-dose prophylaxis.
Pilger D; Hauser A; Kuecherer C; Mugenyi K; Kabasinguzi R; Somogyi S; Harms G; Kunz A
Antivir Ther; 2011; 16(1):109-13. PubMed ID: 21311114
[TBL] [Abstract][Full Text] [Related]
19. Variability in the plasma concentration of efavirenz and nevirapine is associated with genotypic resistance after treatment interruption.
Darwich L; Esteve A; Ruiz L; Bellido R; Clotet B; Martinez-Picado J
Antivir Ther; 2008; 13(7):945-51. PubMed ID: 19043929
[TBL] [Abstract][Full Text] [Related]
20. Antiretroviral drug-resistant mutations at baseline and at time of failure of antiretroviral therapy in HIV type 1-coinfected TB patients.
Rajesh L; Karunaianantham R; Narayanan PR; Swaminathan S
AIDS Res Hum Retroviruses; 2009 Nov; 25(11):1179-85. PubMed ID: 19895208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]